Cash flow Jinhai Medical Technology Limited

Equities

2225

KYG5140Y1162

Employment Services

Delayed Hong Kong S.E. Other stock markets 06:39:44 08/06/2026 BST			5-day change	1st Jan Change
3.350 ^HKD	-5.37%		+0.30%	+168.80%

03-30	Jinhai Medical Technology's 2025 Loss Narrows; Shares Drop 12%	MT
03-27	Jinhai Medical Technology Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI

5d569.JMdEOugsghYFeIVkfjWlfXG8njFb4l1OWLurfzVvaiw.EvEiWNpp11BhJ7wTKEbOJQbl5F42rRgaYOnKPnQBCwFhgi5ssXjhRTYa7g

Published financial data: JINHAI MEDICAL TECHNOLOGY LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	21.42M	22.28M	45.64M	50.24M	46.28M
Total Revenues	21.42M	22.28M	45.64M	50.24M	46.28M
Cost of Goods Sold, Total	13.66M	12.16M	33.62M	38.76M	39.09M
Gross Profit	7.76M	10.12M	12.03M	11.48M	7.19M
Selling General & Admin Expenses, Total	8.71M	10.25M	15.95M	31.95M	25.02M
Provision for Bad Debts	446K	-138K	669K	-387K	183K
Other Operating Expenses	-	-	-	-	-
Other Operating Expenses, Total	9.16M	10.12M	16.62M	31.57M	25.2M
Operating Income	-1.4M	417	-4.59M	-20.09M	-18.01M
Interest Expense, Total	-132K	-85.29K	-221K	-773K	-675K
Interest And Investment Income	176K	447K	359K	288K	69K
Net Interest Expenses	43.9K	361K	138K	-485K	-606K
Currency Exchange Gains (Loss)	184K	113K	-632K	284K	-281K
Other Non Operating Income (Expenses)	553K	553K	2.61M	1.46M	1.1M
EBT, Excl. Unusual Items	-620K	1.03M	-2.47M	-18.83M	-17.8M
Gain (Loss) On Sale Of Investments	-805K	-890K	-1.02M	232K	499K
Gain (Loss) On Sale Of Assets	277K	147K	-15K	17K	10K
Asset Writedown	-83.7K	-	-	-	-
Insurance Settlements	80.05K	180K	100K	185K	126K
Other Unusual Items	1.12M	319K	191K	173K	-
EBT, Incl. Unusual Items	-28.19K	784K	-3.22M	-18.23M	-17.16M
Income Tax Expense	435K	668K	895K	28K	233K
Earnings From Continuing Operations	-464K	116K	-4.11M	-18.26M	-17.4M
Net Income to Company	-464K	116K	-4.11M	-18.26M	-17.4M
Minority Interest	252K	352K	971K	290K	315K
Net Income - (IS)	-212K	468K	-3.14M	-17.96M	-17.08M
Net Income to Common Incl Extra Items	-212K	468K	-3.14M	-17.96M	-17.08M
Net Income to Common Excl. Extra Items	-212K	468K	-3.14M	-17.96M	-17.08M
Per Share Items
Net EPS - Basic	-0	0	-0	-0	-0
Basic EPS - Continuing Operations	-0	0	-0	-0	-0
Basic Weighted Average Shares Outstanding	4.92B	4.92B	4.97B	5.17B	5.22B
Net EPS - Diluted	-0	0	-0	-0	-0
Diluted EPS - Continuing Operations	-0	0	-0	-0	-0
Diluted Weighted Average Shares Outstanding	4.92B	4.92B	4.97B	5.17B	5.22B
Normalized Basic EPS	-0	0	-0	-0	-0
Normalized Diluted EPS	-0	0	-0	-0	-0
Dividend Per Share	-	-	-	-	-
Payout Ratio	-	-	-	-	-
Supplemental Items
EBITDA	2.36M	3.57M	-1.32M	-16.29M	-14.39M
EBITA	-1.4M	417	-4.59M	-20.09M	-18.01M
EBIT	-1.4M	417	-4.59M	-20.09M	-18.01M
EBITDAR	2.21M	3.41M	-1.46M	-14.2M	-14.37M
Total Revenues (As Reported)	21.42M	-	-	-	-
Effective Tax Rate - (Ratio)	-1.54K	85.24	-27.82	-0.15	-1.36
Current Domestic Taxes	-	-	28K	-	141K
Current Foreign Taxes	-	-	748K	10K	81K
Total Current Taxes	441K	663K	776K	10K	222K
Deferred Domestic Taxes	-	-	-	-	-
Deferred Foreign Taxes	-	-	-	-	-
Total Deferred Taxes	-5.41K	5.58K	119K	18K	11K
Normalized Net Income	-136K	995K	-575K	-11.48M	-10.81M
Interest on Long-Term Debt	113K	61.71K	202K	402K	298K
Supplemental Operating Expense Items
Selling and Marketing Expenses	17.97K	12.15K	13K	11K	553K
General and Administrative Expenses	8.7M	10.24M	15.94M	31.94M	24.46M
Research And Development Expense From Footnotes	-	-	-	-	742K
Net Rental Expense, Total	-149K	-161K	-139K	2.09M	20K
Imputed Operating Lease Interest Expense	-42.87K	-34.78K	-33.83K	1.05M	7.34K
Imputed Operating Lease Depreciation	-106K	-126K	-105K	1.04M	12.66K
Maintenance & Repair Expenses, Total	-	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	-	-	-	13.15M	9.12M
Total Stock-Based Compensation	-	-	-	13.15M	9.12M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	14.64M	15.38M	20.2M	10.45M	35.59M
Short Term Investments	921K	3.08M	3.34M	2.33M	2.1M
Trading Asset Securities, Total	8.74M	7.59M	6.56M	4.48M	1.19M
Total Cash And Short Term Investments	24.29M	26.05M	30.1M	17.26M	38.88M
Accounts Receivable, Total	1.46M	2.21M	5.53M	4.86M	15.38M
Other Receivables	2.52M	1.3M	1.96M	1.63M	1.59M
Notes Receivable	29.6K	1K	114K	112K	108K
Total Receivables	4.02M	3.51M	7.61M	6.6M	17.08M
Inventory	874K	959K	2.1M	2.77M	3M
Prepaid Expenses	148K	187K	-	-	-
Other Current Assets, Total	1.29M	2.59M	2.88M	3.54M	5.47M
Total Current Assets	30.62M	33.3M	42.68M	30.16M	64.43M
Gross Property Plant And Equipment	10.39M	14.5M	13.91M	14.1M	13.07M
Accumulated Depreciation	-8.56M	-8.78M	-7.48M	-7.8M	-8.49M
Net Property Plant And Equipment	1.83M	5.73M	6.43M	6.3M	4.58M
Long-term Investments	-	-	558K	556K	539K
Goodwill	-	-	-	522K	522K
Loans Receivable Long-Term	33.18K	2.04K	-	-	-
Deferred Tax Assets Long-Term	189K	159K	39K	21K	10K
Other Long-Term Assets, Total	1.01M	1.08M	12.51M	21.31M	18.75M
Total Assets	33.69M	40.27M	62.22M	58.87M	88.83M
Liabilities
Accounts Payable, Total	264K	477K	5.46M	5.13M	16.4M
Accrued Expenses, Total	3.3M	4.52M	4.57M	3.54M	2.65M
Short-term Borrowings	-	968K	4.72M	10.8M	11.97M
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	1.61M	1.8M	1.89M	991K	1.08M
Current Income Taxes Payable	432K	695K	885K	-	-
Unearned Revenue Current, Total	1.2M	2.09M	534K	1.36M	611K
Other Current Liabilities	1.43M	3.45M	3.19M	1.54M	2.3M
Total Current Liabilities	8.23M	14M	21.25M	23.36M	35.02M
Long-Term Debt	-	968K	-	-	-
Long-Term Leases	254K	713K	3.48M	2.73M	1.86M
Unearned Revenue Non Current	-	-	-	-	-
Deferred Tax Liability Non Current	25.05K	-	-	-	-
Total Liabilities	8.51M	15.68M	24.73M	26.09M	36.87M
Common Stock, Total	2.14M	2.14M	2.25M	2.25M	2.3M
Additional Paid In Capital	14.96M	14.96M	32.32M	32.32M	58.78M
Retained Earnings	6.8M	6.12M	1.68M	-16.29M	-31.97M
Comprehensive Income and Other	1.52M	1.15M	1.23M	13.52M	22.17M
Total Common Equity	25.42M	24.37M	37.47M	31.81M	51.29M
Minority Interest	-251K	224K	16K	973K	674K
Total Equity	25.17M	24.59M	37.49M	32.78M	51.96M
Total Liabilities And Equity	33.69M	40.27M	62.22M	58.87M	88.83M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4.92B	4.92B	5.17B	5.17B	5.29B
ECS Total Common Shares Outstanding	4.92B	4.92B	5.17B	5.17B	5.29B
Book Value / Share	0.01	0	0.01	0.01	0.01
Tangible Book Value	25.42M	24.37M	37.47M	31.28M	50.77M
Tangible Book Value Per Share	0.01	0	0.01	0.01	0.01
Total Debt	1.87M	4.45M	10.08M	14.52M	14.91M
Net Debt	-22.43M	-21.6M	-20.01M	-2.73M	-23.97M
Debt Equivalent Oper. Leases	-1.19M	-1.29M	-1.11M	16.71M	160K
Minority Interest, Total (Incl. Fin. Div)	-251K	224K	16K	973K	674K
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	460K	450K	331K	465K	686K
Inventories - Work In Process, Total	-	507K	224K	339K	409K
Inventories - Finished Goods, Total	413K	1.15K	1.54M	1.96M	1.91M
Buildings, Total	4.17M	4.17M	4.16M	4.16M	4.16M
Machinery, Total	2.08M	4.59M	1.83M	3.4M	3.26M
Full Time Employees	370	520	694	488	485
Accumulated Allowance for Doubtful Accounts (Supple)	1.07M	968K	1.68M	1.27M	1.33M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-212K	468K	-3.14M	-17.96M	-17.08M
Depreciation & Amortization - CF	5.37M	4.39M	4.1M	5.02M	4.62M
Depreciation & Amortization, Total	5.37M	4.39M	4.1M	5.02M	4.62M
(Gain) Loss From Sale Of Asset	-277K	-147K	15K	-17K	-10K
(Gain) Loss on Sale of Investments - (CF)	805K	890K	1.02M	-232K	-499K
Asset Writedown & Restructuring Costs	83.7K	-	-	-	-
Stock-Based Compensation (CF)	-	-	-	13.15M	9.12M
Provision and Write-off of Bad Debts	446K	-138K	669K	-387K	183K
Other Operating Activities, Total	153K	-544K	-899K	-659K	234K
Change In Accounts Receivable	-581K	-677K	-6.06M	1.89M	-12.29M
Change In Inventories	-874K	-41.71K	-1.87M	-672K	-235K
Change In Accounts Payable	-1.79M	617K	5.82M	-4.21M	11.15M
Change in Unearned Revenues	732K	1.04M	-1.56M	825K	-748K
Change in Other Net Operating Assets	-488K	-1.61M	-	-	-
Cash from Operations	3.37M	4.24M	-1.91M	-3.26M	-5.57M
Capital Expenditure	-607K	-1.18M	-1.24M	-1.01M	-95K
Sale of Property, Plant, and Equipment	361K	466K	568K	-	52K
Cash Acquisitions	-	-1.14M	-6.8M	300K	-
Divestitures	-	-	1.15M	17K	-
Sale (Purchase) of Real Estate properties	-	-	-	-11.17M	-218K
Investment in Marketable and Equity Securities, Total	-2.57M	254K	-558K	2.36M	3.78M
Other Investing Activities, Total	176K	447K	359K	288K	69K
Cash from Investing	-2.64M	-1.15M	-6.51M	-9.22M	3.59M
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	-	6.35M	2.01M
Total Debt Issued	-	-	-	6.35M	2.01M
Short Term Debt Repaid, Total	-	-	-	-	-500K
Long-Term Debt Repaid, Total	-4.68M	-3.83M	-3.69M	-3.06M	-958K
Total Debt Repaid	-4.68M	-3.83M	-3.69M	-3.06M	-1.46M
Issuance of Common Stock	-	-	17.47M	-	26.51M
Common Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Other Financing Activities, Total	-132K	109K	-160K	-354K	-675K
Cash from Financing	-4.81M	-3.72M	13.62M	2.93M	26.39M
Foreign Exchange Rate Adjustments	122K	-242K	-394K	-210K	725K
Net Change in Cash	-3.97M	-872K	4.81M	-9.75M	25.14M
Supplemental Items
Cash Interest Paid	132K	85.29K	221K	773K	675K
Cash Income Tax Paid (Refund)	408K	400K	685K	874K	290K
Levered Free Cash Flow	2.21M	4.08M	-2.06M	718K	-287K
Unlevered Free Cash Flow	2.29M	4.13M	-1.93M	1.2M	135K
Change In Net Working Capital	1.59M	-926K	1.92M	3.4M	2.25M
Net Debt Issued / Repaid	-4.68M	-3.83M	-3.69M	3.29M	554K

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-2.39	0	-5.6	-20.74	-15.24
Return on Total Capital	-3.02	0	-7.5	-26.47	-19.72
Return On Equity %	-1.83	0.48	-13.25	-51.96	-41.05
Return on Common Equity	-0.83	1.92	-10.16	-51.86	-41.11
Margin Analysis
Gross Profit Margin %	36.24	45.4	26.35	22.84	15.54
SG&A Margin	40.69	46.02	34.95	63.6	54.06
EBITDA Margin %	11.02	16.03	-2.9	-32.42	-31.1
EBITA Margin %	-6.54	0	-10.06	-39.99	-38.92
EBIT Margin %	-6.54	0	-10.06	-39.99	-38.92
Income From Continuing Operations Margin %	-2.16	0.52	-9.01	-36.33	-37.59
Net Income Margin %	-0.99	2.1	-6.88	-35.76	-36.91
Net Avail. For Common Margin %	-0.99	2.1	-6.88	-35.76	-36.91
Normalized Net Income Margin	-0.64	4.46	-1.26	-22.85	-23.36
Levered Free Cash Flow Margin	10.32	18.32	-4.52	1.43	-0.62
Unlevered Free Cash Flow Margin	10.7	18.56	-4.22	2.39	0.29
Asset Turnover
Asset Turnover	0.59	0.6	0.89	0.83	0.63
Fixed Assets Turnover	7	5.9	7.51	7.9	8.51
Receivables Turnover (Average Receivables)	11.43	12.12	11.79	9.67	4.57
Inventory Turnover (Average Inventory)	-	13.28	22	15.93	13.54
Short Term Liquidity
Current Ratio	3.72	2.38	2.01	1.29	1.84
Quick Ratio	3.44	2.11	1.77	1.02	1.6
Operating Cash Flow to Current Liabilities	0.41	0.3	-0.09	-0.14	-0.16
Days Sales Outstanding (Average Receivables)	31.93	30.11	30.96	37.83	79.82
Days Outstanding Inventory (Average Inventory)	-	27.49	16.59	22.97	26.95
Average Days Payable Outstanding	-	11.03	31.19	49.15	99.92
Cash Conversion Cycle (Average Days)	-	46.57	16.36	11.66	6.86
Long Term Solvency
Total Debt/Equity	7.42	18.09	26.89	44.3	28.69
Total Debt / Total Capital	6.91	15.32	21.19	30.7	22.29
LT Debt/Equity	1.01	6.84	9.28	8.33	3.57
Long-Term Debt / Total Capital	0.94	5.79	7.31	5.77	2.78
Total Liabilities / Total Assets	25.27	38.93	39.75	44.32	41.51
EBIT / Interest Expense	-10.58	0	-20.79	-25.99	-26.68
EBITDA / Interest Expense	29.97	51.44	-2.23	-19.5	-19.84
(EBITDA - Capex) / Interest Expense	25.38	37.63	-7.81	-20.8	-19.98
Total Debt / EBITDA	0.47	1.01	-20.49	-0.96	-1.11
Net Debt / EBITDA	-5.66	-4.92	40.68	0.18	1.79
Total Debt / (EBITDA - Capex)	0.56	1.39	-5.84	-0.9	-1.11
Net Debt / (EBITDA - Capex)	-6.68	-6.73	11.59	0.17	1.78
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-4.7	1.75	104.87	10.07	-7.89
Gross Profit, 1 Yr. Growth %	-12.36	30.92	18.91	-4.59	-37.36
EBITDA, 1 Yr. Growth %	9.63	53.51	-137.1	1.13K	-11.63
EBITA, 1 Yr. Growth %	-24.33	-100.03	-	337.29	-10.35
EBIT, 1 Yr. Growth %	-24.33	-100.03	-	337.29	-10.35
Earnings From Cont. Operations, 1 Yr. Growth %	-136.71	-123.25	-3.64K	343.94	-4.71
Net Income, 1 Yr. Growth %	-116.79	-290.12	-771.15	471.95	-4.93
Normalized Net Income, 1 Yr. Growth %	-87.63	-358.54	-157.84	2.39K	-5.86
Diluted EPS Before Extra, 1 Yr. Growth %	-116.8	-290	-764.21	450.55	-5.76
Accounts Receivable, 1 Yr. Growth %	-35.8	50.98	150.05	-12.2	216.8
Inventory, 1 Yr. Growth %	-	9.72	118.67	32.05	8.49
Net Property, Plant and Equip., 1 Yr. Growth %	-57.32	212.96	12.26	-2.07	-27.32
Total Assets, 1 Yr. Growth %	-14.53	19.26	54.5	-5.39	50.91
Tangible Book Value, 1 Yr. Growth %	-0.26	0.38	53.78	-16.52	62.27
Common Equity, 1 Yr. Growth %	-0.26	0.38	53.78	-15.13	61.25
Cash From Operations, 1 Yr. Growth %	-54.41	27.02	-145.04	70.42	71
Capital Expenditures, 1 Yr. Growth %	341.5	94.06	4.84	-18.3	-90.58
Levered Free Cash Flow, 1 Yr. Growth %	-65.25	-17.67	-150.56	-134.81	-139.98
Unlevered Free Cash Flow, 1 Yr. Growth %	-65.03	-17.96	-146.57	-162.4	-88.78
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-35.76	-0.43	44.38	50.17	0.69
Gross Profit, 2 Yr. CAGR %	-20.84	6.88	24.77	6.51	-22.69
EBITDA, 2 Yr. CAGR %	-13.71	28.8	-24.53	113.56	229.59
EBITA, 2 Yr. CAGR %	27.38	-98.5	78.99	-	98
EBIT, 2 Yr. CAGR %	27.38	-98.5	78.99	-	98
Earnings From Cont. Operations, 2 Yr. CAGR %	-17.78	-69.73	187.4	1.15K	105.68
Net Income, 2 Yr. CAGR %	-44.4	-39.12	257.18	519.57	133.19
Normalized Net Income, 2 Yr. CAGR %	-50.76	-4.9	22.28	239.78	383.94
Diluted EPS Before Extra, 2 Yr. CAGR %	-44.38	-39.08	255.25	504.72	127.78
Accounts Receivable, 2 Yr. CAGR %	-52.29	-1.55	94.32	48.17	66.78
Inventory, 2 Yr. CAGR %	-	-	54.93	69.92	19.69
Net Property, Plant and Equip., 2 Yr. CAGR %	-48.7	15.57	87.43	4.85	-15.63
Total Assets, 2 Yr. CAGR %	-11.12	1.08	35.74	20.9	19.49
Tangible Book Value, 2 Yr. CAGR %	2.49	-2.23	24.25	13.31	16.39
Common Equity, 2 Yr. CAGR %	2.49	-2.23	24.25	14.25	16.99
Cash From Operations, 2 Yr. CAGR %	-34.73	-24.21	-24.37	-12.39	70.71
Capital Expenditures, 2 Yr. CAGR %	-3.15	192.71	42.63	-7.45	-72.26
Levered Free Cash Flow, 2 Yr. CAGR %	-38.07	-19.88	-35.48	-58.05	-62.7
Unlevered Free Cash Flow, 2 Yr. CAGR %	-38.36	-20.57	-38.19	-46.09	-73.54
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-23.3	-24.56	26.64	31.9	27.59
Gross Profit, 3 Yr. CAGR %	-4.43	-6.52	10.75	14.1	-10.76
EBITDA, 3 Yr. CAGR %	-5.85	4.06	-14.94	91.3	59.14
EBITA, 3 Yr. CAGR %	-29.04	-92.15	35.4	141.07	-
EBIT, 3 Yr. CAGR %	-29.04	-92.15	35.4	141.07	-
Earnings From Cont. Operations, 3 Yr. CAGR %	-49.21	-44.74	48.21	232.23	431.28
Net Income, 3 Yr. CAGR %	-60.87	-11.95	35.48	317.87	231.7
Normalized Net Income, 3 Yr. CAGR %	-59.69	21.03	-19.43	210.17	121.5
Diluted EPS Before Extra, 3 Yr. CAGR %	-60.89	-11.91	35.08	311.11	225.43
Accounts Receivable, 3 Yr. CAGR %	-42.1	-29.96	34.33	49.11	90.88
Inventory, 3 Yr. CAGR %	-	-	-	46.89	46.32
Net Property, Plant and Equip., 3 Yr. CAGR %	-17.3	-6.27	14.46	50.96	-7.21
Total Assets, 3 Yr. CAGR %	-0.12	-1.89	16.44	20.35	30.18
Tangible Book Value, 3 Yr. CAGR %	0.71	0.23	13.71	8.82	27.72
Common Equity, 3 Yr. CAGR %	0.71	0.23	13.71	9.42	28.15
Cash From Operations, 3 Yr. CAGR %	14.37	-18.73	-36.28	-0.85	9.49
Capital Expenditures, 3 Yr. CAGR %	25.07	22.1	107.87	18.45	-56.8
Levered Free Cash Flow, 3 Yr. CAGR %	205.42	-10.85	-31.28	-47.48	-58.72
Unlevered Free Cash Flow, 3 Yr. CAGR %	205.81	-11.83	-33.52	-38	-68.06
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-13.82	-12.9	-0.78	-0.65	15.54
Gross Profit, 5 Yr. CAGR %	-12.94	-2.9	6.23	-1.51	-4.08
EBITDA, 5 Yr. CAGR %	-22.06	-8.05	-14.07	38.73	46.23
EBITA, 5 Yr. CAGR %	-28.64	-84.45	3.23	87.67	57.63
EBIT, 5 Yr. CAGR %	-28.64	-84.45	3.23	87.67	57.63
Earnings From Cont. Operations, 5 Yr. CAGR %	-41.24	-44.9	3.05	92.77	68.97
Net Income, 5 Yr. CAGR %	-49.75	-27.13	-2.36	92.15	68.35
Normalized Net Income, 5 Yr. CAGR %	-51.06	-17.35	-22.65	82.89	57.94
Diluted EPS Before Extra, 5 Yr. CAGR %	-51.52	-29.12	-2.58	90.35	66.48
Accounts Receivable, 5 Yr. CAGR %	-21.9	-22.73	-6.02	-5.48	46.47
Net Property, Plant and Equip., 5 Yr. CAGR %	-11.83	9.36	14.72	-1.97	1.31
Total Assets, 5 Yr. CAGR %	4.88	1.1	12.98	6.66	17.65
Tangible Book Value, 5 Yr. CAGR %	20.58	-3.65	8.53	5.27	14.77
Common Equity, 5 Yr. CAGR %	20.58	-3.65	8.53	5.62	15.01
Cash From Operations, 5 Yr. CAGR %	-14.38	24.13	-3.22	-16.25	-5.49
Capital Expenditures, 5 Yr. CAGR %	-13.5	3.18	31.82	9.29	-7.13
Levered Free Cash Flow, 5 Yr. CAGR %	-23.79	-4.66	92.75	-34.06	-46.18
Unlevered Free Cash Flow, 5 Yr. CAGR %	-23.25	-4.41	88.85	-27.58	-54.02